Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4882)
All Articles published online
|
Jul 14, 2005 (publication date) through Jan 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang WH, Huang JQ, Zheng GF, Xia HHX, Wong WM, Lam SK, Wong BCY. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A meta-analysis. World J Gastroenterol 2005; 11(26): 4067-4077 [PMID: 15996033 DOI: 10.3748/wjg.v11.i26.4067] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i26/4067.htm |
| Number | Citing Articles |
| 1 |
Friederike S. Luetzenberg, Nancy Jiang. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties. The Laryngoscope 2020; 130(2): 321 doi: 10.1002/lary.27916
|
| 2 |
M. A. Ovsepian, E. V. Barkalova, D. N. Andreev, I. V. Maev. Optimizing the treatment of patients with gastroesophageal reflux disease: focus on nutritional risk factors and nutritional approaches. Meditsinskiy sovet = Medical Council 2023; (8): 51 doi: 10.21518/ms2023-124
|
| 3 |
Alan B. R. Thomson. Standard doses of the oral proton pump inhibitors are clinically equivalent: A comparison. Current GERD Reports 2007; 1(4): 223 doi: 10.1007/s12171-007-0022-0
|
| 4 |
S. L. Shah, B. E. Lacy, J. K. DiBaise, M. F. Vela, M. D. Crowell. The impact of obesity on oesophageal acid exposure time on and off proton pump inhibitor therapy. Alimentary Pharmacology & Therapeutics 2015; 42(9): 1093 doi: 10.1111/apt.13394
|
| 5 |
Alex Mejia, Walter K Kraft. Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology 2009; 2(3): 295 doi: 10.1586/ecp.09.8
|
| 6 |
Eric Hassall, Wendy Kerr, Hashem B. El-Serag. Characteristics of Children Receiving Proton Pump Inhibitors Continuously for Up to 11 Years Duration. The Journal of Pediatrics 2007; 150(3): 262 doi: 10.1016/j.jpeds.2006.08.078
|
| 7 |
Jeremy Klein, Robert T. Kavitt. Gastroesophageal Reflux Disease. 2023; : 61 doi: 10.1007/978-3-031-48241-0_8
|
| 8 |
Qin Ding, Shuqi Huang, Zexu Sun, Kaifeng Chen, Xin Li, Qi Pei. A Review of Population Pharmacokinetic Models of Posaconazole. Drug Design, Development and Therapy 2022; : 3691 doi: 10.2147/DDDT.S384637
|
| 9 |
Gabriella Boccia, Francesco Manguso, Erasmo Miele, Roberta Buonavolontà, Annamaria Staiano. Maintenance Therapy for Erosive Esophagitis in Children After Healing by Omeprazole: Is It Advisable?. The American Journal of Gastroenterology 2007; 102(6): 1291 doi: 10.1111/j.1572-0241.2007.01152.x
|
| 10 |
Anthony M. Brade, Houda Bahig, Andrea Bezjak, Rosalyn A. Juergens, Charmaine Lynden, Nicolas Marcoux, Barbara Melosky, Devin Schellenberg, Stephanie Snow. Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process. Current Oncology 2024; 31(11): 6512 doi: 10.3390/curroncol31110483
|
| 11 |
Tiberiu Hershcovici, Ronnie Fass. Gastro-Oesophageal Reflux Disease. Drugs 2011; 71(18): 2381 doi: 10.2165/11597300-000000000-00000
|
| 12 |
Daniel A. Kroch, Ryan D. Madanick. Medical Treatment of Gastroesophageal Reflux Disease. World Journal of Surgery 2017; 41(7): 1678 doi: 10.1007/s00268-017-3954-2
|
| 13 |
Wai-Kit Lo, Hiroshi Mashimo. Failed Anti-Reflux Therapy. 2017; : 19 doi: 10.1007/978-3-319-46885-3_3
|
| 14 |
Anna C. Shawyer, Joanne D’Souza, Julia Pemberton, Helene Flageole. The management of postoperative reflux in congenital esophageal atresia–tracheoesophageal fistula: a systematic review. Pediatric Surgery International 2014; 30(10): 987 doi: 10.1007/s00383-014-3548-0
|
| 15 |
Charles Muller, Natalie Tapaskar, Robert T. Kavitt. Foregut Surgery. 2020; : 121 doi: 10.1007/978-3-030-27592-1_14
|
| 16 |
Alannah Quinlivan, Zsuzsanna H. McMahan, Eun Bong Lee, Mandana Nikpour. Gastrointestinal Tract Considerations Part I. Rheumatic Disease Clinics of North America 2023; 49(2): 295 doi: 10.1016/j.rdc.2023.01.006
|
| 17 |
Carla Maradey-Romero, Ronnie Fass. New and Future Drug Development for Gastroesophageal Reflux Disease. Journal of Neurogastroenterology and Motility 2014; 20(1): 6 doi: 10.5056/jnm.2014.20.1.6
|
| 18 |
Azaan Ramani, Alisha Merchant, Brooks D. Cash. Review of the clinical development of fexuprazan for gastroesophageal reflux–related disease. European Journal of Clinical Pharmacology 2023; 79(8): 1023 doi: 10.1007/s00228-023-03521-4
|
| 19 |
Sean Smithgall. Medications for the Gut. Physician Assistant Clinics 2023; 8(2): 339 doi: 10.1016/j.cpha.2022.10.011
|
| 20 |
Su Hyun Park, Kang Nyeong Lee, Oh Young Lee, Myung Gyu Choi, Jie-Hyun Kim, In-Kyung Sung, Jae Young Jang, Kyung Sik Park, Hoon Jai Chun, Eun Young Kim, Jun Kyu Lee, Jin Seok Jang, Gwang Ha Kim, Su Jin Hong, Yong Chan Lee, Suck-Chei Choi, Hyun Soo Kim, Tae Oh Kim, Gwang Ho Baik, Yong Cheol Jeon. A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease. Gut and Liver 2023; 17(2): 226 doi: 10.5009/gnl220023
|
| 21 |
Eda Eken, David S Estores, Emily J Cicali, Kristin K Wiisanen, Julie A Johnson. A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps. Pharmacogenomics and Personalized Medicine 2023; : 645 doi: 10.2147/PGPM.S371994
|
| 22 |
Delaney Provenza, Christopher Gillette, Brian Peacock, Jared Rejeski. Managing heartburn and reflux in primary care. JAAPA 2024; 37(3): 24 doi: 10.1097/01.JAA.0001005620.54669.f4
|
| 23 |
Daniel Martin Simadibrata, Elvira Lesmana, Yeong Yeh Lee. Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?. Expert Opinion on Investigational Drugs 2024; 33(10): 1009 doi: 10.1080/13543784.2024.2393868
|
| 24 |
Daniela Jodorkovsky, John W. Blackett. Laryngopharyngeal and Gastroesophageal Reflux. 2020; : 271 doi: 10.1007/978-3-030-48890-1_30
|
| 25 |
Nilanka Wickramasinghe, Niranga Manjuri Devanarayana. Unveiling the intricacies: Insight into gastroesophageal reflux disease. World Journal of Gastroenterology 2025; 31(1): 98479 doi: 10.3748/wjg.v31.i1.98479
|
| 26 |
Dieter Deforce, George Wade, Brigitte Bloechl-Daum. Clinical Pharmacology: Current Topics and Case Studies. 2016; : 317 doi: 10.1007/978-3-319-27347-1_20
|
| 27 |
M.A. Valdovinos-Diaz, M. Amieva-Balmori, R. Carmona-Sánchez, E. Coss-Adame, O. Gómez-Escudero, M. González-Martínez, F. Huerta-Iga, E. Morel-Cerda, J.M. Remes-Troche, J.L. Tamayo-de la Cuesta, G. Torres-Villalobos, L.R. Valdovinos-García, G. Vázquez-Elizondo, A.S. Villar-Chávez, J.S. Arenas-Martínez. Recomendaciones de buena práctica clínica en el diagnóstico y tratamiento de la enfermedad por reflujo gastroesofágico. Revisión por expertos de la Asociación Mexicana de Gastroenterología. Revista de Gastroenterología de México 2024; 89(1): 121 doi: 10.1016/j.rgmx.2023.12.002
|
| 28 |
George Wade, Brigitte Bloechl-Daum. Clinical Pharmacology: Current Topics and Case Studies. 2010; : 345 doi: 10.1007/978-3-7091-0144-5_23
|
| 29 |
Cameron W. Pierce. A Stitch in Time: Rethinking the Rationale for Empiric PPIs in the ACG GERD Guideline. American Journal of Gastroenterology 2022; 117(11): 1883 doi: 10.14309/ajg.0000000000001936
|
| 30 |
Adharsh Ravindran, Prasad G. Iyer. Geriatric Gastroenterology. 2021; : 1161 doi: 10.1007/978-3-030-30192-7_42
|
| 31 |
M.A. Valdovinos Díaz, M. Amieva-Balmori, R. Carmona-Sánchez, E. Coss-Adame, O. Gómez-Escudero, M. González-Martínez, F. Huerta-Iga, E. Morel-Cerda, J.M. Remes-Troche, J.L. Tamayo-de la Cuesta, G. Torres-Villalobos, L.R. Valdovinos-García, G. Vázquez-Elizondo, A.S. Villar-Chávez, J.A. Arenas-Martínez. Good clinical practice recommendations for the diagnosis and treatment of gastroesophageal reflux disease. An expert review from the Asociación Mexicana de Gastroenterología. Revista de Gastroenterología de México (English Edition) 2024; 89(1): 121 doi: 10.1016/j.rgmxen.2023.12.002
|
| 32 |
Alex Mejia, Walter K. Kraft. Pharmacology and Therapeutics. 2009; : 457 doi: 10.1016/B978-1-4160-3291-5.50035-4
|
| 33 |
Adharsh Ravindran, Prasad G. Iyer. Geriatric Gastroenterology. 2020; : 1 doi: 10.1007/978-3-319-90761-1_42-1
|
| 34 |
Missale Solomon, James C. Reynolds. Geriatric Gastroenterology. 2012; : 311 doi: 10.1007/978-1-4419-1623-5_31
|
| 35 |
Carla Maradey-Romero, Ronnie Fass. Diagnosis and Treatment of Gastroesophageal Reflux Disease. 2016; : 93 doi: 10.1007/978-3-319-19524-7_6
|
| 36 |
Mohammed A. Alzahrani, Abdullah M. Alqaraawi, Saeed R. Alzubide, Ehab Abufarhaneh, Saad S. Alkhowaiter, Mohammed Alsulaimi, Resheed Alkhiari, Ahmed S. AlMalki, Abdulrahman A. Alfadda, Emad S. Aljahdli, Fahad I. Alsohaibani, Abid H. AlLehibi, Majid A. Almadi. The Saudi Gastroenterology Association consensus on the clinical care pathway for the diagnosis and treatment of GERD. Saudi Journal of Gastroenterology 2024; 30(6): 353 doi: 10.4103/sjg.sjg_82_24
|
| 37 |
Wai-Kit Lo, Hilary J. Goldberg, Steve Boukedes, Robert Burakoff, Walter W. Chan. Proton Pump Inhibitors Independently Protect Against Early Allograft Injury or Chronic Rejection After Lung Transplantation. Digestive Diseases and Sciences 2018; 63(2): 403 doi: 10.1007/s10620-017-4827-0
|
| 38 |
Hang Viet Dao, Long Bao Hoang, Hue Thi Minh Luu, Hoa Lan Nguyen, Robert Joel Goldberg, Jeroan Allison, An Thi Minh Dao, Hong Thi Van Nguyen, Tomoaki Matsumura, Long Van Dao. Clinical symptoms, endoscopic findings, and lower esophageal sphincter characteristics in patients with absent contractility. Medicine 2022; 101(43): e31428 doi: 10.1097/MD.0000000000031428
|
| 39 |
Kathleen J. Motil, Arthur Beisang, Constance Smith-Hicks, Anthony Lembo, Shannon M. Standridge, Edwin Liu. Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome. Expert Review of Gastroenterology & Hepatology 2024; 18(6): 227 doi: 10.1080/17474124.2024.2368014
|
| 40 |
Eun Jin Kim, Oh Young Lee, Kang Nyeong Lee, Sung Joon Lee, Jae-Young Jang, Jin Woong Cho, Tae-Oh Kim. Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study. Journal of Neurogastroenterology and Motility 2019; 25(3): 403 doi: 10.5056/jnm18185
|
| 41 |
Barbara Ruaro, Riccardo Pozzan, Paola Confalonieri, Stefano Tavano, Michael Hughes, Marco Matucci Cerinic, Elisa Baratella, Elisabetta Zanatta, Selene Lerda, Pietro Geri, Marco Confalonieri, Francesco Salton. Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?. Pharmaceuticals 2022; 15(8): 1033 doi: 10.3390/ph15081033
|
| 42 |
Grace Snow, Shumon I. Dhar, Lee M. Akst. How to Understand and Treat Laryngopharyngeal Reflux. Gastroenterology Clinics of North America 2021; 50(4): 871 doi: 10.1016/j.gtc.2021.08.002
|
| 43 |
Philip O. Katz, Kerry B. Dunbar, Felice H. Schnoll-Sussman, Katarina B. Greer, Rena Yadlapati, Stuart Jon Spechler. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 2022; 117(1): 27 doi: 10.14309/ajg.0000000000001538
|
| 44 |
Anna C. Shawyer, Julia Pemberton, Helene Flageole. Post-operative management of esophageal atresia–tracheoesophageal fistula and gastroesophageal reflux: A Canadian Association of Pediatric Surgeons annual meeting survey. Journal of Pediatric Surgery 2014; 49(5): 716 doi: 10.1016/j.jpedsurg.2014.02.052
|
| 45 |
Tiberiu Hershcovici, Ronnie Fass. Pharmacological management of GERD: where does it stand now?. Trends in Pharmacological Sciences 2011; 32(4): 258 doi: 10.1016/j.tips.2011.02.007
|
| 46 |
Brigitte Blöchl-Daum. "Me-too drugs" und das Konzept des Klasseneffekts. Wiener Medizinische Wochenschrift 2006; 156(17-18): 494 doi: 10.1007/s10354-006-0333-2
|
| 47 |
Hamid Reza Azizollahi, Mandana Rafeey. Efficacy of proton pump inhibitors and H2 blocker in the treatment of symptomatic gastroesophageal reflux disease in infants. Korean Journal of Pediatrics 2016; 59(5): 226 doi: 10.3345/kjp.2016.59.5.226
|
| 48 |
Preeti Dhar, Eddy Fan. Non-Pulmonary Complications of Critical Care. Respiratory Medicine 2014; : 105 doi: 10.1007/978-1-4939-0873-8_5
|
| 49 |
Yao-Kuang Wang, Wen-Hung Hsu, Sophie S. W. Wang, Chien-Yu Lu, Fu-Chen Kuo, Yu-Chung Su, Sheau-Fang Yang, Chiao-Yun Chen, Deng-Chyang Wu, Chao-Hung Kuo. Current Pharmacological Management of Gastroesophageal Reflux Disease. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/983653
|
| 50 |
Melissa A. Barnhart, Mary L. Thomas, Alana J. Schilthuis, Christopher D. Jackson. Know Your Guidelines Series: The ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease Review. Southern Medical Journal 2022; 115(12): 919 doi: 10.14423/SMJ.0000000000001473
|
| 51 |
Perçin Serhat Yergin, Sema Zer Toros. Airway Diseases. 2023; : 2523 doi: 10.1007/978-3-031-22483-6_134-1
|
| 52 |
Sophida Boonsathorn, Iek Cheng, Frank Kloprogge, Carlos Alonso, Charmion Lee, Bilyana Doncheva, John Booth, Robert Chiesa, Adam Irwin, Joseph F. Standing. Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children. Clinical Pharmacokinetics 2019; 58(1): 53 doi: 10.1007/s40262-018-0658-1
|
| 53 |
Ronnie Fass. Alternative Therapeutic Approaches to Chronic Proton Pump Inhibitor Treatment. Clinical Gastroenterology and Hepatology 2012; 10(4): 338 doi: 10.1016/j.cgh.2011.12.020
|
| 54 |
Vasundhara Tolia. Esomeprazole Use in Pediatrics. Pediatric Health 2008; 2(6): 687 doi: 10.2217/17455111.2.6.687
|
| 55 |
Harland Winter, Philip Kum‐Nji, Suleman H Mahomedy, Jaroslaw Kierkus, Michelle Hinz, Huihua Li, Mary K Maguire, Gail M Comer. Efficacy and Safety of Pantoprazole Delayed‐release Granules for Oral Suspension in a Placebo‐controlled Treatment‐withdrawal Study in Infants 1–11 Months Old With Symptomatic GERD. Journal of Pediatric Gastroenterology and Nutrition 2010; 50(6): 609 doi: 10.1097/MPG.0b013e3181c2bf41
|
| 56 |
Matthias Hoch, Felix Huth, Masahiko Sato, Tirtha Sengupta, Michelle Quinlan, Stephanie Dodd, Shruti Kapoor, Florence Hourcade‐Potelleret. Pharmacokinetics of asciminib in the presence of CYP3A or P‐gp inhibitors, CYP3A inducers, and acid‐reducing agents. Clinical and Translational Science 2022; 15(7): 1698 doi: 10.1111/cts.13285
|
| 57 |
Pablo Cañamares-Orbís, Francis K.L. Chan. Endoscopic management of nonvariceal upper gastrointestinal bleeding. Best Practice & Research Clinical Gastroenterology 2019; : 101608 doi: 10.1016/j.bpg.2019.04.001
|
| 58 |
Nicolas Chapelle, Ines Ben Ghezala, Alan Barkun, Marc Bardou. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD). Expert Opinion on Pharmacotherapy 2021; 22(2): 219 doi: 10.1080/14656566.2020.1817385
|